Allocating rewards among both the individual and team performance is most effective for increasing physical activity.su that ve cay an xoa
Does it help to reward people if you want them to exercise more? Yes, but try a combination of individual and team incentives, says Mitesh Patel, MD, MBA, MS, of the University of Pennsylvania. He led a study1 in the Journal of General Internal Medicine2, published by Springer, that also showed how smartphones can be a hassle-free way to monitor people's exercise programs.
Despite many associated health benefits, less than half of adults in the US do the bare minimum of exercise. It is extremely difficult to get people to exercise more, especially if they lead sedentary lives and are overweight.
Dr. Patel's group used insights gathered from behavioral economics to develop a team-based exercise intervention. The trial consisted of a 13-week intervention period and a 13-week follow-up period. It challenged 304 employees from an organization in Philadelphia, divided up into 76 four-member teams, to take at least 7000 steps a day. Participants received daily feedback on how well they fared.
There were four types of teams: a control group, one in which rewards were based on individual performance, another in which rewards were based on the team's combined effort, and a fourth in which rewards were based on a combination of individual and team performance. A winning team was drawn in each arm every other day and money was only paid if the step goals were achieved, according to the incentive allocation applicable to each arm.
cay an xoa tri ung thu gan
These results - and the use of kinase inhibitors in oncology per se - are the central topic of the Spring conference of the Austrian Society of Haematology and Medical Oncology (OeGHO), which is taking place in Vienna on 17 - 19 March. Jäger, who is also chairman of this conference, says: "In targeted therapy, blood cancers serve as a model system for many different types of cancer. Knowledge obtained from haematology is therefore of great interest to other oncologists."
The reason: targeted treatment acts on specific molecular-biological properties of the cancer cell. Tissue samples have to be taken in order to determine these properties. Such samples must also be taken if follow-up tests are necessary during treatment. In the case of solid tumours, a surgical procedure is usually required to take a tissue sample and this is not only stressful to the patient but also carries a certain risk. Jäger: "In the case of haematological malignancies, we can obtain millions of cells quickly, easily and cheaply by taking a blood sample or performing a bone marrow puncture and use these for testing."
cay an xoa
Does it help to reward people if you want them to exercise more? Yes, but try a combination of individual and team incentives, says Mitesh Patel, MD, MBA, MS, of the University of Pennsylvania. He led a study1 in the Journal of General Internal Medicine2, published by Springer, that also showed how smartphones can be a hassle-free way to monitor people's exercise programs.
Despite many associated health benefits, less than half of adults in the US do the bare minimum of exercise. It is extremely difficult to get people to exercise more, especially if they lead sedentary lives and are overweight.
Dr. Patel's group used insights gathered from behavioral economics to develop a team-based exercise intervention. The trial consisted of a 13-week intervention period and a 13-week follow-up period. It challenged 304 employees from an organization in Philadelphia, divided up into 76 four-member teams, to take at least 7000 steps a day. Participants received daily feedback on how well they fared.
There were four types of teams: a control group, one in which rewards were based on individual performance, another in which rewards were based on the team's combined effort, and a fourth in which rewards were based on a combination of individual and team performance. A winning team was drawn in each arm every other day and money was only paid if the step goals were achieved, according to the incentive allocation applicable to each arm.
cay an xoa tri ung thu gan
These results - and the use of kinase inhibitors in oncology per se - are the central topic of the Spring conference of the Austrian Society of Haematology and Medical Oncology (OeGHO), which is taking place in Vienna on 17 - 19 March. Jäger, who is also chairman of this conference, says: "In targeted therapy, blood cancers serve as a model system for many different types of cancer. Knowledge obtained from haematology is therefore of great interest to other oncologists."
The reason: targeted treatment acts on specific molecular-biological properties of the cancer cell. Tissue samples have to be taken in order to determine these properties. Such samples must also be taken if follow-up tests are necessary during treatment. In the case of solid tumours, a surgical procedure is usually required to take a tissue sample and this is not only stressful to the patient but also carries a certain risk. Jäger: "In the case of haematological malignancies, we can obtain millions of cells quickly, easily and cheaply by taking a blood sample or performing a bone marrow puncture and use these for testing."
cay an xoa